Meeting the challenge of genetic advance.
作者信息
Gill M, Richards T
出版信息
BMJ. 1998 Feb 21;316(7131):570. doi: 10.1136/bmj.316.7131.570.
Abstract
摘要
相似文献
1
Meeting the challenge of genetic advance.应对基因进步的挑战。
BMJ. 1998 Feb 21;316(7131):570. doi: 10.1136/bmj.316.7131.570.
2
The AJMG SEQUENCE: Decoding news and trends for the medical genetics community. Too much? Not enough?《美国医学遗传学杂志》系列：解读医学遗传学领域的新闻与趋势。过多？不足？
Am J Med Genet A. 2010 Jul;152A(7):fmvii-fmviii. doi: 10.1002/ajmg.a.33591.
3
Tech.sight. Genetic testing--present and future.科技视野。基因检测——现状与未来。
Science. 2000 Sep 15;289(5486):1890-2. doi: 10.1126/science.289.5486.1890.
4
A look at the possible impact of new genetic technology on the life insurance industry.审视新基因技术对人寿保险行业可能产生的影响。
J Insur Med. 1995;27(3):207-13.
5
Putting genetics in perspective.正确看待遗传学。
BMJ. 2001 Apr 28;322(7293):1005-6. doi: 10.1136/bmj.322.7293.1005.
6
[Medical genetics. Between consultation and molecular genetic research--an analysis of the current status].[医学遗传学。在咨询与分子遗传学研究之间——当前状况分析]
Fortschr Med. 1995 Dec 20;113(35-36):499-502.
7
Research in the wild.野外研究。
Nature. 2007 Nov 22;450(7169):478. doi: 10.1038/450478c.
8
Clinical genetics: compassion, access, science, and advocacy.临床遗传学：同情、可及性、科学与宣传。
Genet Med. 2001 Nov-Dec;3(6):426-9. doi: 10.1097/00125817-200111000-00009.
9
Genetic technologies and achieving health for populations.基因技术与实现全民健康。
Int J Health Serv. 2000;30(2):407-24. doi: 10.2190/E3P3-TQ8D-KTDR-NF8K.
10
The new genetics. Implications for clinical services in Britain and the United States.新遗传学。对英国和美国临床服务的影响。
BMJ. 1998 Mar 7;316(7133):767-70. doi: 10.1136/bmj.316.7133.767.
引用本文的文献
1
Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases.初级保健中乳腺癌和卵巢癌家族史解读的计算机支持：与模拟病例的比较研究
BMJ. 2000 Jul 1;321(7252):28-32. doi: 10.1136/bmj.321.7252.28.
2
Controversy in primary care: Should asymptomatic haemochromatosis be treated?基层医疗中的争议：无症状性血色素沉着症是否应接受治疗？
BMJ. 2000 May 13;320(7245):1314-7. doi: 10.1136/bmj.320.7245.1314.
3
Rational or rationed medicine? The promise of genetics for improved clinical practice.合理用药还是定量配给用药？遗传学对改善临床实践的前景。
BMJ. 2000 Apr 1;320(7239):933-5. doi: 10.1136/bmj.320.7239.933.
4
More collaboration is needed about benefits of new genetic screening tests.需要就新的基因筛查测试的益处开展更多合作。
BMJ. 1998 Aug 15;317(7156):471. doi: 10.1136/bmj.317.7156.471a.
5
Genetics consortiums can offer views facilitating best practice in Alzheimer's disease.遗传学联盟可以提供有助于阿尔茨海默病最佳实践的观点。
BMJ. 1998 Aug 15;317(7156):471. doi: 10.1136/bmj.317.7156.471.
本文引用的文献
1
Prognosis of BRCA1 hereditary breast cancer.
Lancet. 1998 Jan 31;351(9099):304-5. doi: 10.1016/S0140-6736(98)22005-8.
2
The new genetics in clinical practice.临床实践中的新遗传学
BMJ. 1998 Feb 21;316(7131):618-20. doi: 10.1136/bmj.316.7131.618.
3
Alzheimer's disease.阿尔茨海默病
BMJ. 1998 Feb 7;316(7129):446-8. doi: 10.1136/bmj.316.7129.446.
4
Hippocratic or hypocritic: birth pangs of an ethical code.希波克拉底式的还是伪善的：一种道德准则的诞生阵痛。
Nat Genet. 1998 Jan;18(1):18. doi: 10.1038/ng0198-18.
5
BRCA genes--bookmaking, fortunetelling, and medical care.BRCA基因——赌博、算命与医疗保健。
N Engl J Med. 1997 May 15;336(20):1448-9. doi: 10.1056/NEJM199705153362009.
6
Consent, confidentiality, and research.
N Engl J Med. 1997 Mar 20;336(12):869-70. doi: 10.1056/NEJM199703203361209.
7
Ethical issues in genetic research: disclosure and informed consent.基因研究中的伦理问题：信息披露与知情同意
Nat Genet. 1997 Jan;15(1):16-20. doi: 10.1038/ng0197-16.
8
Brave new now.当下的全新世界。
Nat Genet. 1997 Jan;15(1):1-2. doi: 10.1038/ng0197-1.
9
Pitfalls of genetic testing.基因检测的陷阱。
N Engl J Med. 1996 May 2;334(18):1192-4. doi: 10.1056/NEJM199605023341812.
Zotero 插件